Company Description

Pelagos Pharmaceuticals is developing orally bioavailable small molecule drugs to target diseases of aging by modulating nuclear hormone receptors that regulate cellular metabolism. Its lead program targets estrogen-related receptor (ERR) to treat obesity while preserving muscle mass.